WHO ICTRP trial
Treatment of Obesity by Intraparietogastric Injection of Botulinum Toxin
ChiCTR-TRC-09000413 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-09000413 |
|---|---|
| Public title | Treatment of Obesity by Intraparietogastric Injection of Botulinum Toxin |
| Scientific title | Treatment of Obesity by Intraparietogastric Injection of Botulinum Toxin |
| Primary sponsor | Chinese PLA General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Pilot study |
| Countries | China |
| Conditions | Obesity |
| Interventions | group I:intraparietogastric injection of botulinum toxin type A 200U ;group II:intraparietogastric injection of botulinum toxin type A 300U |
| Registration date | May 21, 2009 |
| Target size | group I:25;group II:25 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: